pTau 217/beta-amyloid 1-42 in plasma (Lumipulse G)
Jump to navigation
Jump to search
Indications
- diagnostic workup for potential Alzheimer's disease[1] (FDA-approved)
* circumvents need for PET scan
Methods
- presumably mass spectrometry
More general terms
Components
References
- ↑ 1.0 1.1 George J FDA Clears First Blood Test for Alzheimer's Diagnosis Plasma assessment is not intended as a screening or stand-alone diagnostic test, agency says. MedPage Today May 16, 2025 https://www.medpagetoday.com/neurology/alzheimersdisease/115631
- ↑ Palmqvist S, Warmenhoven N, Anastasi F et al Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform. Nat Med. 2025 Jun;31(6):2036-2043. PMID: https://pubmed.ncbi.nlm.nih.gov/40205199 PMCID: PMC12176611 Free PMC article. https://pmc.ncbi.nlm.nih.gov/articles/PMC12176611/
- ↑ Salvado G, Janelidze S, Bali D et al. Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurol. 2025. Sept 15 PMID: https://pubmed.ncbi.nlm.nih.gov/40952756 https://jamanetwork.com/journals/jamaneurology/fullarticle/2838887